Medtronic announces schedule for presentations at the 2022 north american neuromodulation society meeting

Sessions will include dtm™ scs endurance therapy 3-month outcomes for patients with chronic back and leg pain dublin, jan. 12, 2022 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced its schedule for presentations at the 25th annual north american neuromodulation society meeting, taking place january 13-15, 2022 in orlando, florida. medtronic therapies and technologies will be represented as part of 23 podium and poster presentations.
MDT Ratings Summary
MDT Quant Ranking